Human Epidermal Growth Factor Receptor 2–Targeting [<sup>68</sup>Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer
Ali Alhuseinalkhudhur(Uppsala University), Jens Nørkær Sørensen(Technical University of Denmark), Fredrik Y. Frejd(Uppsala University), Joachim Feldwisch(Uppsala University), Henrik Lindman(Uppsala University), Caroline Rönnlund(Karolinska University Hospital), Tora Sundin(Uppsala University Hospital), Mark Lubberink(Uppsala University), Vladimir Tolmachev(Uppsala University), Per Liss(Uppsala University), Irina Velikyan(Uppsala University), Victor Vishwanath Iyer(Uppsala University), Johan Hartman(Karolinska University Hospital)
Cited by 49
Related Papers
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
|Circulation|2019|513
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
|PLoS ONE|2009|504
Artificial intelligence as the next step towards precision pathology
|Journal of Internal Medicine|2020|443
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial
|The Lancet|2000|343
Quantitative Assessment of Myocardial Perfusion in the Detection of Significant Coronary Artery Disease
|Journal of the American College of Cardiology|2014|324